Merrimack

About:

Merrimack is a biopharmaceutical company that designs and develops medicines to treat cancer.

Top Investors: Hercules Capital, National Institutes of Health, Expansion Venture Capital, Credit Suisse, Unilever Ventures

Description:

Merrimack Pharmaceuticals discovers, designs, and develops therapies for the treatment of diseases in the areas of autoimmunity and cancer. Their systems biology is to apply capabilities to build functional and predictive computational models of biological systems such as cell signaling networks.

Total Funding Amount:

$432M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Cambridge, Massachusetts, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)merrimack.com

Founders:

Gavin MacBeath, Ulrik Nielsen

Number of Employees:

11-50

Last Funding Date:

2018-07-02

IPO Status:

Public

Industries:

Biotechnology

Health Care

Pharmaceutical